Technology transfer / Localization · GCC · Announced 30 Nov 2025

Algorithm → Batterjee Pharma

Lebanon's Algorithm signed a strategic partnership with Batterjee Pharma to manufacture its lipid and blood-pressure products in Saudi Arabia, with full technology transfer targeted by mid-2026.

Parties: Algorithm (Lebanon) → Batterjee Pharma (Saudi Arabia)

Value
Undisclosed
Territory
Saudi Arabia
Therapeutic area
Cardiovascular
Assets
Lipid-lowering products; Antihypertensive products
Announced
30 Nov 2025

Our analysis

Why this matters

On 30 November 2025, Batterjee Pharma and Lebanon's Algorithm announced a strategic partnership to localise manufacture and supply of Algorithm products holding European and Japanese licences in Saudi Arabia. The deal covers full transfer of manufacturing technology, targeted for completion by mid-2026. Products are treatments for hyperlipidaemia, dyslipidaemia and hypertension; the molecules were not named. No financial terms were disclosed. The article describes Algorithm as the first Lebanese company to localise some of its registered products in the Saudi market.

For BD directors at mid-sized Levant and North African companies: Saudi localisation is not only for multinationals. A local contract partner can protect market access as procurement rules favour local products.

The full analysis is free to read with a work email on this page.

Source: Souq Al Dawaa Saudi

Latest deals

All GCC deals → · All technology transfer / localization deals → · Browse all emerging-market pharma deals →